What is the cost of institutional rot?

Today, the FDA sent a warning letter to Novo Nordisk about systemic failures in their reporting of adverse events, specifically for Novo's blockbuster GLP1 medicine.

However... with RFK in charge of America's public health organs, we know RFK has a vendetta against GLP1s.

https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/novo-nordisk-inc-717576-03052026

#NovoNordisk #glp1 #fda #medicine

Novo Nordisk Faces Shifting Weight-Loss Drug Market

Novo Nordisk forecasts sales drop of 5-13% in 2026 for Wegovy and Ozempic due to rivals like Eli Lilly. Learn how this affects drug prices and future growth.

#NovoNordisk, #Wegovy, #Ozempic, #WeightLossDrugs, #EliLilly

https://newsletter.tf/novo-nordisk-wegovy-sales-drop-2026-competition/

Novo Nordisk's sales are expected to drop by 5% to 13% in 2026, ending years of strong growth. This is due to new weight-loss drugs from competitors.

#NovoNordisk, #Wegovy, #Ozempic, #WeightLossDrugs, #EliLilly

https://newsletter.tf/novo-nordisk-wegovy-sales-drop-2026-competition/

Culture Bourse : « Que faire si on détient du Novo Nordisk ? »

https://vid.freedif.org/w/aUaqWcHaMqNR1UQnBE5xF8